苯并噻唑GPR35拮抗剂的构效关系
Structure-activity relationships of benzothiazole GPR35 antagonists.
作者信息
Abdalhameed Manahil M, Zhao Pingwei, Hurst Dow P, Reggio Patricia H, Abood Mary E, Croatt Mitchell P
机构信息
Department of Chemistry and Biochemistry, Natural Products and Drug Discovery Center, University of North Carolina at Greensboro, Greensboro, NC 27402, United States.
Department of Anatomy and Cell Biology and Center for Substance Abuse Research, Temple University, Philadelphia, PA 19140, United States.
出版信息
Bioorg Med Chem Lett. 2017 Feb 1;27(3):612-615. doi: 10.1016/j.bmcl.2016.12.012. Epub 2016 Dec 5.
Abstract
The first structure-activity relationships for a benzothiazole scaffold acting as an antagonist at GPR35 is presented. Analogues were designed based on a lead compound that was previously determined to have selective activity as a GPR35 antagonist. The synthetic route was modular in nature to independently explore the role of the middle and both ends of the scaffold. The activities of the analogues illustrate the importance of all three segments of the compound.
摘要
首次报道了作为GPR35拮抗剂的苯并噻唑支架的构效关系。基于先前确定具有作为GPR35拮抗剂的选择性活性的先导化合物设计了类似物。合成路线本质上是模块化的，以独立探索支架中间部分和两端的作用。类似物的活性说明了化合物所有三个部分的重要性。
相似文献
1
Structure-activity relationships of benzothiazole GPR35 antagonists.苯并噻唑GPR35拮抗剂的构效关系
Bioorg Med Chem Lett. 2017 Feb 1;27(3):612-615. doi: 10.1016/j.bmcl.2016.12.012. Epub 2016 Dec 5.
2
Label-Free Cell Phenotypic Identification of D-Luciferin as an Agonist for GPR35.无标记细胞表型鉴定D-荧光素作为GPR35的激动剂
Methods Mol Biol. 2016;1461:3-17. doi: 10.1007/978-1-4939-3813-1_1.
3
Synthesis and evaluation of a 2-benzothiazolylphenylmethyl ether class of histamine H4 receptor antagonists.一类2-苯并噻唑基苯基甲基醚组胺H4受体拮抗剂的合成与评价
Bioorg Med Chem Lett. 2016 Nov 1;26(21):5263-5266. doi: 10.1016/j.bmcl.2016.09.049. Epub 2016 Sep 19.
4
Synthesis and evaluation of benzothiazole-based analogues as novel, potent, and selective fatty acid amide hydrolase inhibitors.基于苯并噻唑的类似物作为新型、强效和选择性脂肪酸酰胺水解酶抑制剂的合成与评价
J Med Chem. 2009 Jan 8;52(1):170-80. doi: 10.1021/jm801042a.
5
Design, synthesis, and structure-activity relationship studies of benzothiazole derivatives as antifungal agents.苯并噻唑衍生物作为抗真菌剂的设计、合成及构效关系研究。
Eur J Med Chem. 2016 Nov 10;123:514-522. doi: 10.1016/j.ejmech.2016.07.067. Epub 2016 Jul 29.
6
Synthesis, structure-activity relationships and preliminary antitumor evaluation of benzothiazole-2-thiol derivatives as novel apoptosis inducers.苯并噻唑-2-硫醇衍生物的合成、构效关系及初步抗肿瘤活性评价
Bioorg Med Chem Lett. 2011 Feb 15;21(4):1097-101. doi: 10.1016/j.bmcl.2010.12.124. Epub 2010 Dec 31.
7
The emerging pharmacology and function of GPR35 in the nervous system.GPR35在神经系统中的新兴药理学及功能
Neuropharmacology. 2017 Feb;113(Pt B):661-671. doi: 10.1016/j.neuropharm.2015.07.035. Epub 2015 Jul 29.
8
[Synthesis and antitumor activity of 5-substituted-2-(pyridyl)benzothiazole compounds].5-取代-2-(吡啶基)苯并噻唑化合物的合成及其抗肿瘤活性
Yao Xue Xue Bao. 2013 Jan;48(1):83-8.
9
Structure-based design and synthesis of potent benzothiazole inhibitors of interleukin-2 inducible T cell kinase (ITK).基于结构的设计和合成强效苯并噻唑类白细胞介素 2 诱导的 T 细胞激酶（ITK）抑制剂。
Bioorg Med Chem Lett. 2013 Dec 1;23(23):6331-5. doi: 10.1016/j.bmcl.2013.09.069. Epub 2013 Oct 1.
10
Synthesis and in vitro antitumor activity of new series of benzothiazole and pyrimido[2,1-b]benzothiazole derivatives.新型苯并噻唑和嘧啶并[2,1 - b]苯并噻唑衍生物系列的合成及其体外抗肿瘤活性
Eur J Med Chem. 2014 Oct 6;85:576-92. doi: 10.1016/j.ejmech.2014.07.097. Epub 2014 Jul 29.
引用本文的文献
1
Real samples sensitive dopamine sensor based on poly 1,3-benzothiazol-2-yl((4-carboxlicphenyl)hydrazono)acetonitrile on a glassy carbon electrode.基于玻碳电极上的聚 1,3-苯并噻唑-2-基((4-羧基苯基)腙)乙腈的高灵敏度多巴胺传感器的制备。
Sci Rep. 2024 Jul 18;14(1):16601. doi: 10.1038/s41598-024-65192-0.
2
Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms.大麻素通过不依赖CB1和CB2受体的机制调节神经元活动和癌症。
Front Pharmacol. 2017 Oct 10;8:720. doi: 10.3389/fphar.2017.00720. eCollection 2017.
本文引用的文献
1
Cutting edge: GPR35/CXCR8 is the receptor of the mucosal chemokine CXCL17.前沿：GPR35/CXCR8是黏膜趋化因子CXCL17的受体。
J Immunol. 2015 Jan 1;194(1):29-33. doi: 10.4049/jimmunol.1401704. Epub 2014 Nov 19.
2
Crucial positively charged residues for ligand activation of the GPR35 receptor.GPR35 受体配体激活的关键正电荷残基。
J Biol Chem. 2014 Feb 7;289(6):3625-38. doi: 10.1074/jbc.M113.508382. Epub 2013 Dec 17.
3
Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and β-arrestin2 with antinociceptive activity.帕莫酸靶向孤儿受体 GPR35：一种强效的细胞外信号调节激酶和β-arrestin2 激动剂，具有镇痛活性。
Mol Pharmacol. 2010 Oct;78(4):560-8. doi: 10.1124/mol.110.066746. Epub 2010 Jul 22.
4
New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays.新型亚结构筛选器，可用于从筛选库中去除泛分析干扰化合物（PAINS），并在生物测定中对其进行排除。
J Med Chem. 2010 Apr 8;53(7):2719-40. doi: 10.1021/jm901137j.
5
GPR35 is a functional receptor in rat dorsal root ganglion neurons.GPR35是大鼠背根神经节神经元中的一种功能性受体。
Biochem Biophys Res Commun. 2008 Jan 11;365(2):344-8. doi: 10.1016/j.bbrc.2007.10.197. Epub 2007 Nov 9.
6
Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35.犬尿喹啉酸作为孤儿G蛋白偶联受体GPR35的配体。
J Biol Chem. 2006 Aug 4;281(31):22021-22028. doi: 10.1074/jbc.M603503200. Epub 2006 Jun 5.
7
Molecular delineation of deletions on 2q37.3 in three cases with an Albright hereditary osteodystrophy-like phenotype.三例具有类奥尔布赖特遗传性骨营养不良表型患者2q37.3缺失的分子界定
Clin Genet. 2004 Dec;66(6):537-44. doi: 10.1111/j.1399-0004.2004.00363.x.
8
Cloning of a G-protein-coupled receptor that shows an activity to transform NIH3T3 cells and is expressed in gastric cancer cells.一种G蛋白偶联受体的克隆，该受体具有转化NIH3T3细胞的活性且在胃癌细胞中表达。
Cancer Sci. 2004 Feb;95(2):131-5. doi: 10.1111/j.1349-7006.2004.tb03193.x.
9
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus.编码钙蛋白酶-10的基因中的遗传变异与2型糖尿病有关。
Nat Genet. 2000 Oct;26(2):163-75. doi: 10.1038/79876.
10
Discovery of three novel G-protein-coupled receptor genes.
Genomics. 1998 Jan 15;47(2):310-3. doi: 10.1006/geno.1998.5095.
Zotero 插件